These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus. Plosker GL, Figgitt DP. Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124 [Abstract] [Full Text] [Related]
9. Sitagliptin/metformin fixed-dose combination: in patients with type 2 diabetes mellitus. Chwieduk CM. Drugs; 2011 Feb 12; 71(3):349-61. PubMed ID: 21319871 [Abstract] [Full Text] [Related]
10. Sitagliptin as add-on therapy in insulin deficiency: biomarkers of therapeutic efficacy respond differently in type 1 and type 2 diabetes. Giampietro O, Giampietro C, Bartola LD, Masoni MC, Matteucci E. Drug Des Devel Ther; 2013 Feb 12; 7():99-104. PubMed ID: 23439744 [Abstract] [Full Text] [Related]